Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology. Issue 2 (26th May 2017)

• Record Type: Journal Article
• Authors: Sahakian, Eva; Chen, Jie; Powers, John J; Chen, Xianghong; Maharaj, Kamira; Deng, Susan L; Achille, Alex N; Lienlaf, Maritza; Wang, Hong Wei; Cheng, Fengdong; Sodré, Andressa L; Distler, Allison; Xing, Limin; Perez-Villarroel, Patricio; Wei, Sheng; Villagra, Alejandro; Seto, Ed; Sotomayor, Eduardo M; Horna, Pedro; Pinilla-Ibarz, Javier
• Is Part Of: Journal of leukocyte biology. Volume 102:Issue 2(2017)
• Page Start: 475
• Page End: 486
• Publication Date: 2017-05-26
• Subjects: epigenetics -- innate immunity -- gene regulation; Leucocytes -- Periodicals; Reticulo-endothelial system -- Periodicals; 571.96
• DOI: 10.1189/jlb.1A0415-176RRR
• Languages: English
• ISSNs: 0741-5400

Abstract

Abstract : Expression of HDAC11 may be involved in myeloid cell biology. Abstract: Epigenetic changes in chromatin structure have been recently associated with the deregulated expression of critical genes in normal and malignant processes. HDAC11, the newest member of the HDAC family of enzymes, functions as a negative regulator of IL-10 expression in APCs, as previously described by our lab. However, at the present time, its role in other hematopoietic cells, specifically in neutrophils, has not been fully explored. In this report, for the first time, we present a novel physiologic role for HDAC11 as a multifaceted regulator of neutrophils. Thus far, we have been able to demonstrate a lineage-restricted overexpression of HDAC11 in neutrophils and committed neutrophil precursors (promyelocytes). Additionally, we show that HDAC11 appears to associate with the transcription machinery, possibly regulating the expression of inflammatory and migratory genes in neutrophils. Given the prevalence of neutrophils in the peripheral circulation and their central role in the first line of defense, our results highlight a unique and novel role for HDAC11. With the consideration of the emergence of new, selective HDAC11 inhibitors, we believe that our findings will have significant implications in a wide range of diseases spanning malignancies, autoimmunity, and inflammation.